TrialAnnals of oncology : official journal of the European Society for Medical Oncology2019

Biomarker analysis beyond angiogenesis: RAS/RAF mutation status, tumour sidedness, and second-line ramucirumab efficacy in patients with metastatic colorectal carcinoma from RAISE-a global phase III study.

T Yoshino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.